http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106109434-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-286 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 |
| filingDate | 2016-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106109434-B |
| titleOfInvention | A kind of razaxaban tablet and preparation method thereof |
| abstract | A kind of razaxaban tablet and preparation method thereof, the tablet is made of label, binder solution and coating solution, wherein the formula of the label is as follows: 10 parts of razaxaban；1 part of superfine silica gel powder；70 parts of filler；4.5-6 parts of disintegrating agent；2.5-3.5 parts of magnesium stearate；The formula of binder solution is as follows: 0.9-2.2 parts of adhesive；0.3-0.5 parts of lauryl sodium sulfate；42 parts of purified water；The formula of coating solution is as follows: 2 parts of stomach dissolved film coating pre-mix dose；23 parts of purified water. |
| priorityDate | 2016-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 53.